640 related articles for article (PubMed ID: 28439188)
1. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing Identifies
Peker Eyüboğlu İ; Yenmiş G; Bingöl EN; Yüksel Ş; Tokat F; Özbek P; Güllü Amuran G; Yakıcıer C; Akkiprik M
OMICS; 2020 Jan; 24(1):5-15. PubMed ID: 31851867
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.
Fackenthal JD; Zhang J; Zhang B; Zheng Y; Hagos F; Burrill DR; Niu Q; Huo D; Sveen WE; Ogundiran T; Adebamowo C; Odetunde A; Falusi AG; Olopade OI
Int J Cancer; 2012 Sep; 131(5):1114-23. PubMed ID: 22034289
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.
Cavallone L; Arcand SL; Maugard CM; Nolet S; Gaboury LA; Mes-Masson AM; Ghadirian P; Provencher D; Tonin PN
Fam Cancer; 2010 Dec; 9(4):507-17. PubMed ID: 20694749
[TBL] [Abstract][Full Text] [Related]
6. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.
Francies FZ; Wainstein T; De Leeneer K; Cairns A; Murdoch M; Nietz S; Cubasch H; Poppe B; Van Maerken T; Crombez B; Coene I; Kerr R; Slabbert JP; Vral A; Krause A; Baeyens A; Claes KB
BMC Cancer; 2015 Nov; 15():912. PubMed ID: 26577449
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
8. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Pal T; Bonner D; Cragun D; Monteiro AN; Phelan C; Servais L; Kim J; Narod SA; Akbari MR; Vadaparampil ST
Cancer; 2015 Dec; 121(23):4173-80. PubMed ID: 26287763
[TBL] [Abstract][Full Text] [Related]
9. Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco.
Bakkach J; Mansouri M; Derkaoui T; Loudiyi A; El Fahime E; Barakat A; Ghailani Nourouti N; Martinez De Villarreal J; Cortijo Bringas C; Bennani Mechita M
BMC Cancer; 2020 Sep; 20(1):859. PubMed ID: 32894085
[TBL] [Abstract][Full Text] [Related]
10. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
12. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
[TBL] [Abstract][Full Text] [Related]
13. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
14. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.
Zhang J; Fackenthal JD; Zheng Y; Huo D; Hou N; Niu Q; Zvosec C; Ogundiran TO; Hennis AJ; Leske MC; Nemesure B; Wu SY; Olopade OI
Breast Cancer Res Treat; 2012 Jul; 134(2):889-94. PubMed ID: 22739995
[TBL] [Abstract][Full Text] [Related]
15. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
16. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Li G; Guo X; Tang L; Chen M; Luo X; Peng L; Xu X; Wang S; Xiao Z; Yi W; Dai L; Wang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2011-2024. PubMed ID: 28664449
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
[TBL] [Abstract][Full Text] [Related]
18. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
van der Merwe NC; Oosthuizen J; Theron M; Chong G; Foulkes WD
BMC Cancer; 2020 May; 20(1):391. PubMed ID: 32375709
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan.
Abu-Helalah M; Azab B; Mubaidin R; Ali D; Jafar H; Alshraideh H; Drou N; Awidi A
Sci Rep; 2020 Oct; 10(1):17573. PubMed ID: 33067490
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Nones K; Johnson J; Newell F; Patch AM; Thorne H; Kazakoff SH; de Luca XM; Parsons MT; Ferguson K; Reid LE; McCart Reed AE; Srihari S; Lakis V; Davidson AL; Mukhopadhyay P; Holmes O; Xu Q; Wood S; Leonard C; ; ; ; Beesley J; Harris JM; Barnes D; Degasperi A; Ragan MA; Spurdle AB; Khanna KK; Lakhani SR; Pearson JV; Nik-Zainal S; Chenevix-Trench G; Waddell N; Simpson PT
Ann Oncol; 2019 Jul; 30(7):1071-1079. PubMed ID: 31090900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
